Detalus Advisors
MRK icon

Detalus Advisors’s Merck MRK Stock Holding History

Detalus Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$388K Sell
2,669
-39
-1% -$5.39K 0.08% 129
2026
Q2 		$348K Buy
2,708
+2
+0.1% +$234 0.07% 137
2026
Q1 		$325K Sell
2,706
-232
-8% -$26.8K 0.07% 136
2025
Q4 		$309K Buy
2,938
+277
+10% +$26K 0.08% 135
2025
Q3 		$223K Buy
2,661
+4
+0.2% +$329 0.06% 158
2025
Q2 		$210K Sell
2,657
-37
-1% -$2.94K 0.06% 164
2025
Q1 		$242K Sell
2,694
-20
-0.7% -$1.87K 0.08% 138
2024
Q4 		$270K Sell
2,714
-38
-1% -$3.92K 0.09% 123
2024
Q3 		$312K Sell
2,752
-20
-0.7% -$2.38K 0.1% 115
2024
Q2 		$343K Buy
2,772
+1
+0% +$129 0.12% 98
2024
Q1 		$366K Buy
2,771
+2
+0.1% +$247 0.13% 94
2023
Q4 		$302K Buy
2,769
+1
+0% +$104 0.12% 106
2023
Q3 		$285K Sell
2,768
-198
-7% -$21.3K 0.13% 107
2023
Q2 		$342K Buy
2,966
+201
+7% +$22.8K 0.15% 95
2023
Q1 		$294K Buy
2,765
+2
+0.1% +$216 0.14% 106
2022
Q4 		$307K Sell
2,763
-45
-2% -$4.6K 0.15% 104
2022
Q3 		$242K Sell
2,808
-228
-8% -$20.4K 0.15% 108
2022
Q2 		$277K Sell
3,036
-4,132
-58% -$366K 0.16% 93
2022
Q1 		$588K Sell
7,168
-155
-2% -$12.2K 0.31% 56
2021
Q4 		$561K Sell
7,323
-98
-1% -$7.81K 0.27% 63
2021
Q3 		$557K Buy
7,421
+62
+0.8% +$4.72K 0.28% 61
2021
Q2 		$572K Buy
+7,359
New +$547K 0.3% 57
2020
Q3 		– Sell
-3,331
Closed -$246K – 93
2020
Q2 		$246K Buy
3,331
+3
+0.1% +$226 0.19% 79
2020
Q1 		$244K Buy
3,328
+2
+0.1% +$157 0.22% 70
2019
Q4 		$289K Buy
+3,326
New +$273K 0.21% 79

Other funds holding MRK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Detalus Advisors's MRK Position: Q3 2026 in Review

Detalus Advisors reduced its Merck (MRK) stake by 1.4% in Q3 2026, selling an estimated $5.39K and leaving 2,669 shares worth $388K. The position accounts for 0.08% of the portfolio, ranked #129.

Detalus Advisors first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. The position peaked at $588K in Q1 2022. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Detalus Advisors held 2,669 shares of Merck worth $388K as of Q3 2026.
  • Detalus Advisors sold 39 Merck shares in Q3 2026, an estimated $5.39K.
  • Merck made up 0.08% of Detalus Advisors's portfolio in Q3 2026, its #129 holding.
  • Detalus Advisors first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
  • Detalus Advisors's Merck position peaked at $588K in Q1 2022.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Detalus Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.